S

S

SILFVERDAL , Sven Arne

Last name: SILFVERDAL

First name: Sven Arne

2016 (v1)

Publication

Metadata-only

A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months

Silfverdal, Sven Arne ICARDI, GIANCARLO Vesikari, Timo

Background: Combination vaccines simplify vaccination visits and improve coverage and timeliness. DTaP5-HB-IPV-Hib is a new investigational, fully-liquid, combination vaccine designed to protect against 6 infectious diseases, including 5 pertussis antigens and OMPC instead of PT as conjugated protein for Hib component. Methods: In this...

Uploaded on: May 13, 2023